Occipital Nerve Stimulation to Treat Chronic Headaches
Headache Disorders
About this trial
This is an interventional treatment trial for Headache Disorders focused on measuring Headache, Chronic headache, Migraine, Pain, Cluster headache
Eligibility Criteria
Inclusion Criteria: Be diagnosed with chronic migraine, probable chronic migraine, and/or chronic cluster headache according to the 2004 IHS Classification Criteria (2nd ed.) or be diagnosed with migraine with or without aura Be 18 years of age or older Be willing and able to follow all study-related procedures during the course of the study; Have exhibited refractoriness to two acute medication regimens and two prophylactic medications from two separate preventative classes. Exclusion Criteria: Have received a botulinum toxin (botox) injection for treatment of headache within the last 90 days; Have previously undergone destructive ganglionectomy affecting C2/C3 occipital and/or trigeminal distribution or have an occipital blockade currently in effect; Have had a previous surgery in the intended implant area; Have Arnold-Chiari malformation; Have participated within the last 30 days or plan to participate within the next 4 months in a device or drug trial; Be pregnant or planning on becoming pregnant during the study period; Have an implanted electrical device (e.g., pacemaker, spinal cord stimulator) that may interfere with this therapy; and Currently require, or be likely to require, MRI or diathermy.
Sites / Locations
- Mayo Clinic
- Michigan Head Pain & Neurological Institute